Cancer drugs

These companies develop or sell medicines that treat cancer, such as pills, antibodies and cell therapies.
+8.3%
over 1 month · S&P 500 −2.3%

Key indicators

Health
49 / 100
Fragile
Solid
Price
P/E 40
Cheap
Expensive
Up over 1 year
57 of 105
Wallets over 90 days
2 / 5 buys / sells
Buys
Sells
Health and price: against the other tags.

The 113 companies

LLY
+15.3%
JNJ
+12.8%
ABBV
+4.1%
MRK
Size: weight in the tag. Color: move over the period.
See all companies
L
Eli Lilly
LLY
33.3%
+15.3%
J
Johnson & Johnson
JNJ
16.5%
+12.8%
A
AbbVie
ABBV
12.9%
+4.1%
M
Merck
MRK
9.0%
+1.8%
A
Amgen
AMGN
6.2%
+7.3%
G
Gilead Sciences
GILD
5.2%
+6.8%
P
Pfizer
PFE
4.1%
−0.4%
B
Bristol-Myers Squibb
BMY
3.1%
+4.7%
R
Regeneron Pharmaceuticals
REGN
2.3%
+20.0%
M
Moderna
MRNA
2.2%
−5.6%
R
Revolution Medicines
RVMD
1.1%
−9.0%
I
Incyte
INCY
0.6%
+6.8%
E
Exelixis
EXEL
0.4%
+9.8%
S
Summit Therapeutics
SMMT
0.3%
−7.9%
C
Corcept Therapeutics
CORT
0.2%
−35.7%
I
ImmunityBio
IBRX
0.2%
−39.8%
C
CG Oncology
CGON
0.2%
+20.3%
E
Erasca
ERAS
0.1%
+5.3%
C
Cogent Biosciences
COGT
0.1%
−3.2%
L
Legend Biotech
LEGN
<0.1%
−11.6%
R
Relay Therapeutics
RLAY
<0.1%
+4.6%
T
Tango Therapeutics
TNGX
<0.1%
+12.3%
E
Enliven Therapeutics
ELVN
<0.1%
+24.1%
I
Iovance Biotherapeutics
IOVA
<0.1%
−47.3%
P
Parabilis Medicines
PBLS
<0.1%
+12.9%
C
Celcuity
CELC
<0.1%
+6.7%
I
IDEAYA Biosciences
IDYA
<0.1%
−6.0%
X
Xencor
XNCR
<0.1%
+54.5%
R
Arcus Biosciences
RCUS
<0.1%
−23.6%
B
Biohaven
BHVN
<0.1%
+20.9%
I
Immunome
IMNM
<0.1%
+7.9%
R
Recursion Pharmaceuticals
RXRX
<0.1%
−23.4%
R
Replimune Group
REPL
<0.1%
+86.3%
V
Vir Biotechnology
VIR
<0.1%
−4.9%
Z
Zymeworks
ZYME
<0.1%
+1.9%
S
SELLAS Life Sciences
SLS
<0.1%
−30.7%
P
Precigen
PGEN
<0.1%
−36.9%
N
Nurix Therapeutics
NRIX
<0.1%
−38.0%
N
Nuvation Bio
NUVB
<0.1%
−16.0%
T
Tyra Biosciences
TYRA
<0.1%
+5.2%
D
Damora Therapeutics
DMRA
<0.1%
+15.3%
I
Inhibrx
INBX
<0.1%
−8.0%
V
Verastem
VSTM
<0.1%
−11.4%
C
Corvus Pharmaceuticals
CRVS
<0.1%
+8.0%
A
Aktis Oncology
AKTS
<0.1%
+3.8%
O
Oric Pharmaceuticals
ORIC
<0.1%
−38.4%
S
Syndax Pharmaceuticals
SNDX
<0.1%
−30.8%
R
Rigel Pharmaceuticals
RIGL
<0.1%
−5.9%
O
Obsidian Therapeutics
OBX
<0.1%
+3.0%
A
Aura Biosciences
AURA
<0.1%
+12.1%
S
Sana Biotechnology
SANA
<0.1%
−18.4%
C
Cullinan Therapeutics
CGEM
<0.1%
−26.6%
F
Fulgent Genetics
FLGT
<0.1%
+15.6%
N
Nuvectis Pharma
NVCT
<0.1%
+6.9%
D
Delcath Systems
DCTH
<0.1%
+38.8%
K
Kura Oncology
KURA
<0.1%
−19.9%
C
Candel Therapeutics
CADL
<0.1%
−30.4%
O
Olema Pharmaceuticals
OLMA
<0.1%
+10.0%
J
Janux Therapeutics
JANX
<0.1%
−34.4%
B
Bicara Therapeutics
BCAX
<0.1%
−43.1%
A
ArriVent BioPharma
AVBP
<0.1%
−22.5%
G
Geron
GERN
<0.1%
−21.4%
C
Crescent Biopharma
CBIO
<0.1%
+13.4%
M
Monopar Therapeutics
MNPR
<0.1%
+0.3%
C
CytomX Therapeutics
CTMX
<0.1%
−15.4%
B
BlossomHill Therapeutics
BLSM
<0.1%
−6.4%
A
Arvinas
ARVN
<0.1%
−4.7%
R
Relmada Therapeutics
RLMD
<0.1%
+31.6%
P
Puma Biotechnology
PBYI
<0.1%
−26.1%
C
C4 Therapeutics
CCCC
<0.1%
−0.7%
F
Faeth Therapeutics
FTH
<0.1%
−51.3%
E
Eikon Therapeutics
EIKN
<0.1%
−20.7%
A
Agenus
AGEN
<0.1%
+0.7%
A
Allogene Therapeutics
ALLO
<0.1%
−37.4%
I
Immuneering
IMRX
<0.1%
+1.9%
C
Cypherpunk Technologies
CYPH
<0.1%
−38.1%
Z
Zentalis Pharmaceuticals
ZNTL
<0.1%
−24.1%
S
Sutro Biopharma
STRO
<0.1%
−14.3%
A
ALX Oncology
ALXO
<0.1%
+4.0%
F
Fate Therapeutics
FATE
<0.1%
−33.5%
I
Inovio Pharmaceuticals
INO
<0.1%
+37.5%
P
PDS Biotechnology
PDSB
<0.1%
−32.9%
C
Perspective Therapeutics
CATX
<0.1%
−59.7%
C
Corbus Pharmaceuticals
CRBP
<0.1%
−21.7%
A
Acrivon Therapeutics
ACRV
<0.1%
−17.6%
A
ABVC BioPharma
ABVC
<0.1%
−2.4%
A
Actuate Therapeutics
ACTU
<0.1%
−42.9%
A
Allarity Therapeutics
ALLR
<0.1%
+14.5%
A
AIM ImmunoTech
AIM
<0.1%
−15.7%
B
BioAtla
BCAB
<0.1%
0.0%
A
Ascentage Pharma Group International
AAPG
−0.5%
A
Adagene
ADAG
−28.8%
A
ADC Therapeutics
ADCT
−10.1%
A
Adlai Nortye
ANL
−12.2%
A
Autolus Therapeutics
AUTL
−32.0%
A
AstraZeneca
AZN
+10.7%
B
BioNTech
BNTX
−5.1%
E
Electra Therapeutics
ETRA
+1.0%
G
Genmab
GMAB
+35.8%
G
GSK
GSK
+2.9%
H
HUTCHMED
HCM
+6.9%
I
Iambic Therapeutics
IAM
−30.7%
I
Immunocore
IMCR
+1.6%
I
Immatics
IMTX
−10.5%
J
Jazz Pharmaceuticals
JAZZ
+12.7%
N
Nanobiotix
NBTX
+37.9%
N
Novartis
NVS
+6.7%
O
BeOne Medicines
ONC
+11.4%
R
Roche Holdings
RHHBY
0.0%
T
Takeda Pharmaceutical
TAK
+10.2%
T
Telix Pharmaceuticals
TLX
−12.7%
U
UroGen Pharma
URGN
−28.5%
Z
Zai Lab
ZLAB
+4.6%